H.O.W. Hearing The Ovarian Cancer Whisper - News

OCRFA Research Shows Drugs Help Anti-Tumor Immunity

Wed, 05 Oct 2016 23:43:14 GMT

A team of researchers, including senior author and former OCRFA grantee Rugang Zhang, PhD, have been studying the relationship between PD-1 and PD-L1, a protein and an accompanying molecule, and t-cells, which are a body’s natural defense against tumor growth. PD-L1 can be found on both cancer cells and healthy cells but, when it works […]

Action Alert: Oral Chemotherapy Parity

Fri, 23 Sep 2016 23:37:44 GMT

Join us in asking Congress to pass oral chemotherapy parity legislation today. This legislation will ensure that patients have access to the best chemotherapy drugs available, including many personalized therapies. Send an Action Alert to your Members of Congress Today! Why do we need this action now? The last decade has seen an explosion in […] The post Action Alert: Oral Chemotherapy Parity appeared first on Ovarian Cancer National Alliance.

Report from the Biennial Ovarian Cancer Research Symposium

Wed, 21 Sep 2016 23:32:29 GMT

Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report here, check out a poster on Beyond RECIST 1.1 and a poster on MAGENTA-Making Genetic Testing More Accessible. The post Report from the Biennial Ovarian Cancer Research Symposium appeared first on Ovarian Cancer National Alliance.

SGO and ASCO Agree on Guidelines for Common Type of Ovarian Cancer

Tue, 16 Aug 2016 23:14:17 GMT

(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and followed by surgery. Last week, the Society for Gynecologic Oncology (SGO) and the American Society […]

Impact of Genetic Counseling on Testing and Surgical Prevention in High Risk Women

Mon, 01 Aug 2016 23:08:02 GMT

(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, […]

Women Still Getting CA-125 and CT Testing After Ovarian Cancer, Despite Lack of Clear Benefit

Thu, 28 Jul 2016 23:06:52 GMT

(July 28, 2016) A study published recently in JAMA Oncology showed that CA-125 tests and CT scans are routinely used in ovarian cancer surveillance testing, even though evidence has shown there is no clinical benefit to using these tests. There is no consensus on how to follow a patient in remission from ovarian cancer in […]

Research Study: Meditation

Tue, 26 Jul 2016 23:05:35 GMT

Dr. Anne Reb at Walter Reed National Military Medical Center is currently looking for participants in her research study for women who have been diagnosed with Stage 3 or 4 ovarian cancer and have completed their primary treatment within the last four months and have no clinical evidence of disease. The study will teach you […] The post Research Study: Meditation appeared first on Ovarian Cancer National Alliance.

New Treatment Shows No Benefit for Clear Cell Carcinoma

Mon, 18 Jul 2016 23:04:24 GMT

(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found no significant survival benefit between the groups. The findings of the study, which was conducted in Japan, were reported in the Journal of Clinical Oncology. […]

Study Finds Many Ovarian Cancer Patients Going Untreated

Thu, 07 Jul 2016 23:03:09 GMT

(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are not being treated at all. The researchers analyzed data from more than 210,000 women diagnosed with ovarian cancer in the United States between 2003 and […]

Listen Now: Research Updates from 2016’s Top Medical Meetings

Tue, 05 Jul 2016 23:01:34 GMT

Every year cancer researchers and doctors gather at several professional meetings to present and discuss the latest and most important advances in basic, translational and clinical cancer research. OCRF Scientific Advisory Committee member Douglas A. Levine, MD, highlighted research relevant to ovarian cancer patients presented at the American Society of Clinical Oncology (ASCO), as well […] The post Listen Now: Research Updates from 2016’s Top Medical Meetings appeared first on Ovarian Cancer National Alliance.

The Effect of Oral Contraceptives on Ovarian Cancer

Thu, 23 Jun 2016 23:00:12 GMT

(June 23, 2016) The Journal of Clinical Oncology recently published a study on the role of oral contraceptives (OC) on ovarian cancer prevention. The study, which analyzed data from 21 studies with 5, 584 cases of ovarian cancer, concluded that OC reduced the risk of a variety of invasive ovarian cancers. The risk of developing […]

June 2016 ASCO Highlights

Tue, 21 Jun 2016 22:58:36 GMT

Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meeting by Susan Leighton, Ovarian Cancer Survivor and Research Advocate Since the first time I attended ASCO I have seen the number of abstracts presented about ovarian cancer increase significantly as understanding of the disease has expanded. No longer do we hear the one size […] The post June 2016 ASCO Highlights appeared first on Ovarian Cancer National Alliance.

Capital Ovarian Cancer Organization

Tue, 21 Jun 2016 22:57:16 GMT

The Capital Ovarian Cancer Organization (C.O.C.O.) was founded in August of 2007, in memory Debi Furnish, who died from ovarian cancer in 2005. Around the same time, another woman from Frankfort, Ellen Liebman, died from the disease. Debi’s sister, Beverly Van Houten, and her friend, Jerri Robinson, decided they needed to raise awareness of the […] The post Capital Ovarian Cancer Organization appeared first on Ovarian Cancer National Alliance.

Highlights from the June 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

Mon, 20 Jun 2016 22:54:23 GMT

by Susan Leighton, Ovarian Cancer Survivor and Research Advocate (June 20, 2016) Since the first time I attended ASCO I have seen the number of abstracts presented about ovarian cancer increase significantly as understanding of the disease has expanded. No longer do we hear the one size fits all approach to ovarian cancer; ovarian cancer […]

OCRFA Research Sheds Light on Role of STAT3 in Ovarian Cancer

Fri, 17 Jun 2016 22:52:21 GMT

(June 17, 2016) An OCRFA funded study recently published in Oncogene investigated the role that protein STAT3 plays in the activation and metastasis of ovarian cancer cells. Many women with ovarian cancer develop fluid in the abdomen, which contains cancer cells. Those cells, coupled with a high activation of STAT3, can spread to other areas […]

OCRFA Founder Sol Schreiber passes away

Thu, 09 Jun 2016 22:50:55 GMT

With deep sorrow, Ovarian Cancer Research Fund Alliance mourns the passing of our beloved founder and Chairman Emeritus, Sol Schreiber.

OCRFA Research Shows Genetic Subtypes Linked to Increased Risk of Ovarian Cancer

Thu, 09 Jun 2016 22:49:43 GMT

(June 9, 2016) A ten year, OCRFA-funded study has revealed the effect that the human leukocyte antigen (HLA) genes, which help regulate the body’s immune system, have on how the body responds to treatment of epithelial ovarian cancer. The scientists report that women with certain types of HLA may have an increased risk of ovarian […]

Risk Factors and Outcomes for Chemotherapy Refusal

Tue, 07 Jun 2016 22:48:14 GMT

(June 7, 2016) The Journal of the National Comprehensive Cancer Network recently published a study that looked at the difference in outcomes between two groups of epithelial ovarian cancer patients: those who received recommended, multiagent chemotherapy and those who chose not to undergo the recommended treatment. After tracking thousands of patients in both groups, the […]

SherryStrong.org

Thu, 26 May 2016 22:46:42 GMT

In August of 2014, Sherry Pollex became a part of this incredible, strong, inspirational and ever beautiful community of ovarian cancer survivors. OCRFA first got to know Sherry when she was first diagnosed. We knew right away that Sherry was a special person when her first question was, “How can I help save other women […] The post SherryStrong.org appeared first on Ovarian Cancer National Alliance.

The Impact of BMI on IP Therapy

Wed, 25 May 2016 22:45:39 GMT

(May 25, 2016) A new study published in the International Journal of Gynecological Cancer earlier this month investigated the impact of the impact of body mass index (BMI) on completion, complications, and clinical outcomes of intraperitoneal (IP) chemotherapy in patients with advanced-stage ovarian cancer. The study followed ninety two patients through a minimum of one […]

Action Alert: Protect Ovarian Cancer Research Funding at the Department of Defense

Tue, 24 May 2016 22:43:43 GMT

Later this week, we’ll be sending out a request for you to take Action to help protect ovarian cancer research funding at the Department of Defense. The Ovarian Cancer Research Program (OCRP) is part of the Congressionally Directed Medical Research Program in the Department of Defense (DoD), and funds innovative and cutting edge ovarian cancer […]

Newk’s Raises more than $110,000 for OCRFA

Fri, 20 May 2016 22:42:27 GMT

JACKSON, Miss. (May 17, 2016) – When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis. Blindsided and heartbroken by a type of cancer very few recognize or understand, Lori and her husband Chris, Co-founder and CEO of Newk’s Eatery, […] The post Newk’s Raises more than $110,000 for OCRFA appeared first on Ovarian Cancer National Alliance.

Zubik v. Burwell & the Supreme Court

Tue, 17 May 2016 22:41:12 GMT

FOR IMMEDIATE RELEASE May 17, 2016 Lisa Mauti lmauti@ocrfa.org 202-517-6410 Supreme Court Returns Zubik v. Burwell to Lower Courts to Resolve Access to Cost-Free Contraceptive Services to Women “We urge the lower courts to move quickly and to consider the impact of their decision on the future of women’s preventative healthcare, especially as a […] The post Zubik v. Burwell & the Supreme Court appeared first on Ovarian Cancer National Alliance.

Webinar: Clinical Trials: What you need to know

Mon, 09 May 2016 22:40:03 GMT

Oliver Dorigo, MD, PhD, Director of the Stanford Gynecologic Oncology Clinical Care Program and Director of Stanford Obstetrics and Gynecology’s Division of Gynecologic Oncology provided an introduction to clinical trials for ovarian cancer patients. Dr. Dorigo discussed what clinical trials are, why they are important and how they work, the pros and cons of enrolling […] The post Webinar: Clinical Trials: What you need to know appeared first on Ovarian Cancer National Alliance.

Long Term Survival Study Recruiting Participants

Mon, 09 May 2016 22:38:43 GMT

The Consortium for Long-Term Survival — is bringing together research groups worldwide. These groups include survivors, patient advocates and advocacy groups, (not just researchers) with the goal of “FINDING THE KEY TO LONG-TERM SURVIVAL FOR ALL WOMEN.” RECRUITING NOW: 8+ year survivors, STAGE 3 or 4 ONLY, contact Giulia Fulci, gfulci@partners.org or 617-643-7261. For more […] The post Long Term Survival Study Recruiting Participants appeared first on Ovarian Cancer National Alliance.

OCRFA Research Helps Explain Resistance to Chemotherapy

Wed, 04 May 2016 22:12:18 GMT

(May 4, 2016) Research funded in part by an OCRFA research grant to Dr. Weiping Zou at the University of Michigan has shown that the sensitivity and resistance to cancer chemotherapies is not fully explained by genomic mechanisms as it has previously thought. In fact, it may be affected by effector T cells (cells that defend […]

OVARYact

Tue, 03 May 2016 22:10:44 GMT

Lauren Richards lost her mom Rochelle Richards to ovarian cancer earlier this year. Lauren set out on a mission to make a difference in her community and to honor her mom’s journey. On April 22nd, Lauren hosted a benefit concert called “OVARYact” at Will’s Pub in Orlando, FL. The concert had an admission fee of […] The post OVARYact appeared first on Ovarian Cancer National Alliance.

The Vicki Welsh Fund

Tue, 03 May 2016 22:09:33 GMT

The Vicki Welsh Fund for Ovarian Cancer began 10 years ago, with the goal of fighting ovarian cancer through awareness, education, research, and support. At the heart of the organization is Vicki Welsh, an outgoing and compassionate woman who lost her battle to ovarian cancer in 2006. Sadly, Vicki’s mother-in-law lost her own battle to […] The post The Vicki Welsh Fund appeared first on Ovarian Cancer National Alliance.

Irregular Periods May Increase Ovarian Cancer Risk

Tue, 03 May 2016 22:08:10 GMT

Research published last month in the International Journal of Cancer showed an unexpected finding: young women with irregular menstrual periods may be at higher risk of developing—and dying from—ovarian cancer later in life. The study provides the first evidence linking abnormally long cycles or missed periods to higher ovarian cancer risk. It also challenges a […] The post Irregular Periods May Increase Ovarian Cancer Risk appeared first on Ovarian Cancer National Alliance.

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research

Mon, 02 May 2016 22:06:52 GMT

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-affiliated scientists. Each team, consisting […] The post Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research appeared first on Ovarian Cancer National Alliance.

Hormone Therapy Safe After Nonserous Ovarian Cancer

Mon, 25 Apr 2016 22:05:04 GMT

New findings published online this month in Obstetrics and Gynecology suggest that hormone therapy (HT) can be used safely to manage menopausal symptoms in women who have undergone treatment for nonserous epithelial ovarian cancer. The study showed no reduction in overall survival with HT use in the entire study population, and it appears to positively […] The post Hormone Therapy Safe After Nonserous Ovarian Cancer appeared first on Ovarian Cancer National Alliance.

OCRFA Statement on Results of GOG 252

Mon, 11 Apr 2016 22:03:29 GMT

Many members of the ovarian cancer community have been concerned about the results of GOG 252 clinical trial, which were released last month at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. OCRFA consulted with a team of our scientific experts, and the consensus of the group is that the results of this […]

Georgia Ovarian Cancer Alliance

Fri, 01 Apr 2016 22:01:33 GMT

The Georgia Ovarian Cancer Alliance (GOCA) formed back in 1998, when a group of thirteen ovarian cancer survivors from Atlanta met one another while undergoing chemotherapy. Through their conversations, many of them came to realize that prior to their own diagnosis they had never heard of the disease, or had even met an ovarian cancer […] The post Georgia Ovarian Cancer Alliance appeared first on Ovarian Cancer National Alliance.

Research Update: Updated ICON6 Final Progression Free Survival analysis

Fri, 01 Apr 2016 21:58:21 GMT

The Lancet has recently published an update to the progression-free survival (PFS) data of theICON6 trial. (The preliminary data was first presented at the European Society of Medical Oncology congress in 2013.) ICON6 is a randomized three-arm, three stage, double-blind, placebo-controlled multi-center Gynaecologic Cancer InterGroup (GCIG) phase III trial. ICON6 is designed to evaluate the safety and […] The post Research Update: Updated ICON6 Final Progression Free Survival analysis appeared first on Ovarian Cancer National Alliance.

Updated ICON6 Final Progression Free Survival analysis

Thu, 31 Mar 2016 21:56:59 GMT

(March 31, 2016) The Lancet has recently published an update to the progression-free survival (PFS) data of the ICON6 trial. (The preliminary data was first presented at the European Society of Medical Oncology congress in 2013.) ICON6 is a randomized three-arm, three stage, double-blind, placebo-controlled multi-center Gynaecologic Cancer InterGroup (GCIG) phase III trial. ICON6 is designed to […]

Highlights from the March 2016 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer

Wed, 30 Mar 2016 21:55:06 GMT

By: Annie Ellis, Ovarian Cancer Survivor and Research Advocate Women’s cancer specialists from all over the world convened in San Diego in March to hear about the latest developments in women’s cancer research. This was the fifth SGO annual meeting I’ve attended over the past eight years, and the first that I left with more confusion […] The post Highlights from the March 2016 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer appeared first on Ovarian Cancer National Alliance.

Research Updates from SGO Annual Meeting

Wed, 30 Mar 2016 21:53:34 GMT

OCRFA staff and volunteers recently attended the Society of Gynecologic Oncology’s (SGO) Annual Meeting on Women’s Cancer, held March 19-22, 2016 in San Diego. Every year women’s cancer physicians and researchers gather at this meeting to discuss the latest in the care and treatment of women with ovarian and other gynecologic cancers. OCRFA Research Advocate and […] The post Research Updates from SGO Annual Meeting appeared first on Ovarian Cancer National Alliance.

OCRFA Co-authors Paper on Educating about Hereditary Risk Across Cancer Types

Mon, 28 Mar 2016 21:52:13 GMT

Ovarian Cancer Research Fund Alliance today announced the online publication of a collaborative best practices paper entitled, “Understanding Hereditary Cancer in the Era of Multi-Gene Panel Testing.” The paper offers key insights into the changing needs of individuals and family members who might be at risk for hereditary cancer. The paper also includes discussion of […] The post OCRFA Co-authors Paper on Educating about Hereditary Risk Across Cancer Types appeared first on Ovarian Cancer National Alliance.

Study Defines Characteristics of Long-Term Ovarian Cancer Survivors

Tue, 22 Mar 2016 21:51:07 GMT

(March 22, 2016) A new article in Gynecologic Oncology describes clinical features—some surprising—found in women surviving high-grade serous carcinoma for ten or more years. OCRF Scientific Advisory Committee member and former grantee Douglas A. Levine, MD was senior author of the paper. The study, a joint effort between five academic medical centers, examined 203 long-term […]

Q&A with OCRFA Grantee Jill Madden, Ph.D.

Fri, 18 Mar 2016 21:49:40 GMT

Q&A with Jill Madden, PhD University of Kansas Medical Center Research Institute, Inc. 2016 Ann Schreiber Mentored Investigator Award OCRFA: Tell me about yourself. Did you always want to be a scientist? Were you interested in science as a child? Jill Madden: I grew up on a farm in rural Alden, Iowa, where livestock […]

The Institute of Medicine Reports on Ovarian Cancer

Wed, 16 Mar 2016 21:46:40 GMT

The Institute of Medicine (IOM) recently released a report commissioned by Congress, Ovarian Cancers: Evolving Paradigms in Research and Care. The report provides an in-depth look at the state of ovarian cancer in the United States. While significant progress has been made in the fight against ovarian cancer in the last few decades, the report […]

The Minnesota Ovarian Cancer Alliance

Thu, 03 Mar 2016 22:44:27 GMT

The Minnesota Ovarian Cancer Alliance (MOCA) formed in 1999, when a small group of survivors, united by their doctors, gathered around a dining room table. They realized the lack of ovarian cancer support in their community, and were intent on building a Minnesota ovarian cancer community, made up of survivors and caregivers. The founders were […] The post The Minnesota Ovarian Cancer Alliance appeared first on Ovarian Cancer National Alliance.

Dose-dense Weekly Paclitaxel Does Not Increase PFS

Thu, 03 Mar 2016 22:41:56 GMT

(March 3, 2016) In a study published in the New England Journal of Medicine this week, researchers report that a dose-dense weekly paclitaxel regimen failed to improve progression-free survival in advanced ovarian cancer versus a conventional regimen and optional bevacizumab (Avastin). Patients treated with weekly paclitaxel plus carboplatin had a median PFS of 14.7 months compared […]

Rockin 4A Cause

Wed, 02 Mar 2016 22:40:31 GMT

Rockin 4A Cause was founded by 4 couples who had each lost someone very close to them to three different diseases, including most recently Dyan Elovich Blumberg to ovarian cancer. Together, they found a reason to rock and raise funds with their favorite music with all of their favorite people for 3 important causes. This […] The post Rockin 4A Cause appeared first on Ovarian Cancer National Alliance.

Clinical Trial Highlight: Long-Term Survivor Study

Thu, 25 Feb 2016 22:39:19 GMT

Official Trial Name: The Genomic, Epigenomic, and Psychosocial Characteristics of Long-Term Survivors of Ovarian Cancer – Recruitment. Some advanced-stage ovarian cancer patients are long-term survivors of stages III and IV serum ovarian cancer. These patients may provide the key to long-term survival and bring hope to all women with Stages III and IV ovarian cancer. […] The post Clinical Trial Highlight: Long-Term Survivor Study appeared first on Ovarian Cancer National Alliance.

What You Need to Know About Talcum Powder and Ovarian Cancer

Wed, 24 Feb 2016 22:36:31 GMT

(February 24, 2016) Ovarian Cancer Research Fund Alliance provides information based on medical research and best practices. Research regarding a connection between the use of talcum powder and increased ovarian cancer risk is inconclusive. The verdict of a recent trial regarding talcum powder will not change the information that Ovarian Cancer Research Fund Alliance provides […]

OCRF Research Illuminates Origins of PPM1D Mutations in Ovarian Cancer Patients

Wed, 24 Feb 2016 22:34:38 GMT

(February 24, 2016) Research led by Dr. Elizabeth Swisher at the University of Washington, funded in part by OCRFA and published this month in JAMA Oncology, shows that mutations in the gene PPM1D in women with ovarian cancer are the result of aging and chemotherapy exposure. Click here to read the abstract. Previously, somatic mosaic […]

OCRF Research Defines How Satb1 Gene Goes from Helpful to Harmful in Ovarian Cancer

Mon, 22 Feb 2016 22:33:18 GMT

(February 22, 2016) Imagine a lighthouse on cancer cells that can tell the T-cells in our immune system precisely where to attack to stop cancer in its tracks. When working properly, that’s exactly what dendritic cells do. They break down cancer cells into antigens that T-cells can “read” and know to attack while sparing healthy […]

Advocacy for Ovarian Cancer: Let Your Voice Be Heard!

Mon, 22 Feb 2016 22:30:54 GMT

Join Chad Ramsey, VP of Policy, and Alison Silberman, Director of Field Engagement, on Monday, March 7th at 6pm to learn about OCRFA’s legislative efforts in 2016. You’ll hear about the issues we are working on and learn about ways you can get involved to help make a difference for women with ovarian cancer. Click […] The post Advocacy for Ovarian Cancer: Let Your Voice Be Heard! appeared first on Ovarian Cancer National Alliance.

President Asks for $1B to Fund Cancer “Moon Shot”

Thu, 04 Feb 2016 22:17:19 GMT

In his final State of the Union address, President Obama announced a national initiative to find a cure to cancer. Details are beginning to emerge about the plan and the President has requested $1 Billion in new funding over the next two years to boost the effort. As Congress begins to consider annual appropriations legislation, […] The post President Asks for $1B to Fund Cancer “Moon Shot” appeared first on Ovarian Cancer National Alliance.

Strength in Numbers: OCRF and OCNA Unite to Form OCRFA

Thu, 28 Jan 2016 22:15:23 GMT

As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families.

Increased Risk of Epithelial Ovarian Cancer associated with BRIP1 Gene

Wed, 27 Jan 2016 22:13:26 GMT

(January 27, 2016) A new study of 8,000 women reported in the Journal of the National Cancer Institute reports that carrying mutations in a gene called BRIP1 raised a woman’s chance of getting ovarian cancer in her lifetime to approximately 5%– nearly three times greater than chance women generally have of developing the cancer. Around […]

Meet the New OCRFA!

Wed, 27 Jan 2016 22:11:59 GMT

The Ovarian Cancer National Alliance and Ovarian Cancer Research Fund have led the way in advocacy, research and support for patients and their families for over 22 years. We are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while […] The post Meet the New OCRFA! appeared first on Ovarian Cancer National Alliance.

Foodie Fridays: Mystic Bourbon Liqueur

Fri, 22 Jan 2016 22:10:39 GMT

The 3rd Foodie Friday features Mystic Bourbon Liqueur located in North Carolina. This company was created by two husband and wife teams; Michael & Katie and Jonathan & Marla. The origin of Mystic can be traced back to when Katie discovered the secret on their kitchen stove top. Learn more about this mysterious creation at […] The post Foodie Fridays: Mystic Bourbon Liqueur appeared first on Ovarian Cancer National Alliance.

Foodie Fridays: Chef Marla

Fri, 15 Jan 2016 22:09:31 GMT

From Foodie Delights, Chef Marla Holland is our second featured chef for Foodie Fridays. Her food item for the Turn Up the Heat! Gala will be Seafood Mac & Cheese and Garlic Herb Chicken Lollipops. Those sound scrumptious! Marla Holland has a passion for food that speaks to the soul. She is a personal chef […] The post Foodie Fridays: Chef Marla appeared first on Ovarian Cancer National Alliance.

Hoofbeats for Hope

Fri, 08 Jan 2016 22:07:35 GMT

Hoofbeats to Hope is a dressage musical freestyle horse show and silent auction that started in 2011 to spread awareness in the equestrian community about the early signs and symptoms of ovarian cancer, and to further research for treatment and early detection. Hoofbeats to Hope dedicates their efforts to Marikae Kinross-Wright. Hoofbeats to Hope is […] The post Hoofbeats for Hope appeared first on Ovarian Cancer National Alliance.

OCRF Research Finds Inherited Mutations in 18% with Ovarian Cancer

Fri, 08 Jan 2016 22:01:13 GMT

(Jan. 8, 2016) OCRF grantees Dr. Barbara Norquist and Dr. Elizabeth Swisher were part of a team that recently released a study which investigated the occurrence, and role of, inherited cancer associated genes in a randomly selected population of women diagnosed with ovarian cancer. The OCRF-supported study, published late last month in JAMA Oncology, found […]

Foodie Fridays: Chef Carolyn Stromberg

Fri, 08 Jan 2016 21:59:03 GMT

Welcome to Foodie Fridays! In the weeks leading up to the 11th Annual Turn Up the Heat! Gala, we will feature some of our participating women chefs! The first featured chef is Carolyn Stromberg of Righteous Cheese at Union Market. At her shop, you can find an assortment of delicacies from Manchester, Raclette, Harbison, Brie, […] The post Foodie Fridays: Chef Carolyn Stromberg appeared first on Ovarian Cancer National Alliance.

Teal Tea Foundation

Tue, 05 Jan 2016 21:56:57 GMT

When Jean Shipos had an ovarian cancer recurrence back in 2003, her daughter knew that she wanted to do something based on what she saw her mother go through. Fast-forward three years, Jean and her daughter decided to host a small tea party to help raise awareness of the disease. This “small” tea ended up […] The post Teal Tea Foundation appeared first on Ovarian Cancer National Alliance.